Pacemakers and Cardiac Resynchronization Therapy Pacemakers (CRT-P) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
Summary
GlobalData’s new report, “Pacemakers and Cardiac Resynchronization Therapy Pacemakers (CRT-P) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” provides key data, information and analysis on the global pacemakers and cardiac resynchronization therapy-pacemakers markets. The report provides the market landscape, competitive landscape and market trend information on the pacemakers and cardiac resynchronization therapy-pacemakers markets. The report provides comprehensive information on the key trends affecting the market and key analytical content on the market’s dynamics. The report also reviews the competitive landscape and technology offerings.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
Reasons to buy
Summary
GlobalData’s new report, “Pacemakers and Cardiac Resynchronization Therapy Pacemakers (CRT-P) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” provides key data, information and analysis on the global pacemakers and cardiac resynchronization therapy-pacemakers markets. The report provides the market landscape, competitive landscape and market trend information on the pacemakers and cardiac resynchronization therapy-pacemakers markets. The report provides comprehensive information on the key trends affecting the market and key analytical content on the market’s dynamics. The report also reviews the competitive landscape and technology offerings.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Key segments covered include dual chamber and single chamber pacemakers and cardiac resynchronization therapy-pacemakers.
- Annualized market revenues data from 2003 to 2010, forecast to 2017 and company share data for 2010.
- Qualitative analysis of key market trends, market drivers, and restraints within the pacemakers and cardiac resynchronization therapy pacemakers market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include Medtronic, Boston Scientific, St. Jude Medical, BIOTRONIK and Sorin Group.
Reasons to buy
- Develop business strategies by understanding the trends and developments that are driving the pacemakers and cardiac resynchronization therapy pacemakers market globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
- What’s the next big thing in the pacemakers and cardiac resynchronization therapy-pacemakers market landscape? Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global pacemakers and cardiac resynchronization therapy pacemakers market and the factors shaping it.
1 TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 INTRODUCTION AND OVERVIEW
2.1 Introduction
2.2 GlobalData Report Guidance
3 DISEASE OVERVIEW: CARDIAC ARRYTHMIA AND CONGESTIVE HEART FAILURE (CHF)
3.1 Cardiac Arrhythmia
3.1.1 Bradycardia
3.1.2 Fibrillation
3.2 Congestive Heart Failure (CHF)
3.2.1 Epidemiology
3.3 Diagnosis of Cardiac Arrythmia and Congestive Heart Failure
3.3.1 Electrocardiography (ECG)
3.3.2 Echocardiogram
3.3.3 Holter Monitor (or Continuous Ambulatory Electrocardiographic Monitor)
3.3.4 Trans-Telephonic Monitor (Event Recorder)
3.3.5 Treadmill Testing
3.3.6 Tilt Table Studies
3.3.7 Electro-Physiologic Testing
3.3.8 Trans-Thoracic Echocardiography (TTE) and Echocardiography
3.3.9 Intra-Cardiac Electro-Physiologic Procedure
3.3.10 Cardiac Catheterization
3.3.11 B-Type Natriuretic Peptide (BNP) Level Test
3.4 Treatment Options for Cardiac Arrythmia and Congestive Heart Failure
3.4.1 Lifestyle Changes
3.4.2 Medications
3.4.3 Invasive Therapies
4 DEVICE OVERVIEW
4.1 Pacemakers
4.1.1 Pacemaker Design
4.1.2 Risk Factors Associated with Pacemakers
4.2 Cardiac Resynchronization Therapy-Pacemakers (CRT-P)
4.2.1 Cardiac Resynchronization Therapy-Pacemakers (CRT-P) Design
4.2.2 Cardiac Resynchronization Therapy-Pacemakers (CRT-P) Risk Factors
4.3 Devices Interfering with the Working of Pacemaker and Cardiac Resynchronization Therapy-Pacemakers (CRT-P)
5 GLOBAL PACEMAKERS AND CARDIAC RESYNCHRONIZATION THERAPY-PACEMAKERS: MARKET CHARACTERIZATION
5.1 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Global, Revenue ($m), Historic, 2003-2010
5.2 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Global, Revenue ($m), Forecast, 2010-2017
5.3 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Key Trend
5.3.1 Single Chamber Pacemakers Registered Higher Sales than Dual Chamber Pacemakers in Developing Economies
5.4 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers, Market Dynamics
5.4.1 Market Drivers
5.4.2 Market Restraints
6 PACEMAKERS AND CARDIAC RESYNCHRONIZATION THERAPY-PACEMAKERS MARKET, ANALYSIS BY COUNTRY, REVENUE ($M), 2010-2017
6.1 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The US, Revenue ($m), Historic, 2003-2010
6.2 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The US, Revenue ($m), Forecast, 2010-2017
6.3 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Canada, Revenue ($m), Historic, 2003-2010
6.4 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Canada, Revenue ($m), Forecast, 2010-2017
6.5 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The UK, Revenue ($m), Historic, 2003-2010
6.6 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The UK, Revenue ($m), Forecast, 2010-2017
6.7 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Germany, Revenue ($m), Historic, 2003-2010
6.8 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Germany, Revenue ($m), Forecast, 2010-2017
6.9 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, France, Revenue ($m), Historic, 2003-2010
6.10 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, France, Revenue ($m), Forecast, 2010-2017
6.11 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Italy, Revenue ($m), Historic, 2003-2010
6.12 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Italy, Revenue ($m), Forecast, 2010-2017
6.13 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Spain, Revenue ($m), Historic, 2003-2010
6.14 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Spain, Revenue ($m), Forecast, 2010-2017
6.15 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Japan, Revenue ($m), Historic, 2003-2010
6.16 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Japan, Revenue ($m), Forecast, 2010-2017
6.17 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, China, Revenue ($m), Historic, 2003-2010
6.18 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, China, Revenue ($m), Forecast, 2010-2017
6.19 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, India, Revenue ($m), Historic, 2003-2010
6.20 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, India, Revenue ($m), Forecast, 2010-2017
6.21 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Australia, Revenue ($m), Historic, 2003-2010
6.22 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Australia, Revenue ($m), Forecast, 2010-2017
6.23 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Brazil, Revenue ($m), Historic, 2003-2010
6.24 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Brazil, Revenue ($m), Forecast, 2010-2017
7 PACEMAKERS AND CARDIAC RESYNCHRONIZATION THERAPY-PACEMAKERS MARKET: STRATEGIC COMPETITIVE ASSESSMENT
7.1 Pacemaker and Cardiac Resynchronization Therapy-Pacemakers, Key Market Participants
7.1.1 Medtronic Inc.
7.1.2 St. Jude Medical
7.1.3 BIOTRONIK Inc. GMBH
7.1.4 Boston Scientific
7.1.5 Sorin S.p.A
8 PACEMAKERS AND CARDIAC RESYNCHRONIZATION THERAPY-PACEMAKERS, KEY MARKETED PRODUCTS
8.1 Adapta, Dual Chamber Pacemaker, Medtronic Inc.
8.1.1 Features and Benefits
8.2 EnRythm, Dual Chamber Pacemaker, Medtronic Inc.
8.2.1 Features and Benefits
8.3 Revo MRI SureScan, MRI Safe Dual Chamber Pacemaker, Medtronic Inc.
8.3.1 Features and Benefits
8.4 Advisa MRI SureScan Pacemaker, Dual Chamber MRI Safe Pacemaker, Medtronic Inc.
8.4.1 Features and Benefits
8.5 Accent Wireless Single/Dual Chamber Pacemaker, St. Jude Medical
8.5.1 Features and Benefits
8.6 Entity Dual Chamber Pacemaker, St. Jude Medical
8.6.1 Features and Benefits
8.7 Affinity Dual Chamber Pacemaker, St. Jude Medical
8.7.1 Features and Benefits
8.8 Identity ADx Dual Chamber Pacemaker, St. Jude Medical
8.8.1 Features and Benefits
8.9 Verity ADx Dual Chamber Pacemaker, St. Jude Medical
8.9.1 Features and Benefits
8.10 Regency Single Chamber Pacemaker, St. Jude Medical
8.10.1 Features and Benefits
8.11 Microny Single Chamber Pacemaker, St. Jude Medical
8.11.1 Features and Benefits
8.12 Integrity ADx Dual Chamber Pacemaker, St. Jude Medical
8.12.1 Features and Benefits
8.13 Altrua Group of Single/Dual Chamber Pacemaker, Boston Scientific
8.13.1 Features and Benefits
8.14 ProMRI MRI Safe Single/Dual Chamber Pacemaker, BIOTRONIK
8.14.1 Features and Benefits
8.15 Evia Single/Dual Chamber Pacemaker, BIOTRONIK
8.15.1 Features and Benefits
8.16 Effecta Dual Chamber Pacemaker, BIOTRONIK
8.16.1 Features and Benefits
8.17 Consulta, Medtronic Inc.
8.17.1 Features and Benefits
8.18 Syncra, Medtronic Inc.
8.18.1 Features and Benefits
8.19 Frontier-II, St. Jude Medical
8.19.1 Features and Benefits
8.20 Stratos LV-T, BIOTRONIK
8.20.1 Features and Benefits
9 PACEMAKERS MARKET: STRATEGIC PIPELINE ASSESSMENT
9.1 Pacemakers in Clinical Development Stage
9.1.1 Advisa DR MRI SureScan Pacing System, Medtronic, Inc.
9.1.2 ECN Pacemaker, Mathematical Bio-Solutions, Inc.
9.1.3 Reply MRI Pacemaker, Sorin Group
9.1.4 Ensura MRI SureScan Pacing System, Medtronic, Inc.
9.1.5 Unconditional MRI Compatible Implantable Pacemaker, Kenergy Inc.
9.1.6 Accent MRI Pacemaker, St. Jude Medical
9.1.7 INGENIO 2 PG - MICS, Boston Scientific Corporation
9.2 Pacemaker in Early Development Stage
9.2.1 MicroPort Pacemaker, MicroPort Scientific Corporation
9.3 Pacemakers in Approval Phase
9.3.1 INGENIO Pacemaker System NG, Boston Scientific Corporation
9.4 Pacemakers in Pre-Clinical Development Stage
9.4.1 Aortic Pacemaker
10 PACEMAKERS AND CARDIAC RESYNCHRONIZATION THERAPY-PACEMAKERS MARKET, STRATEGIC DEALS ANALYSIS
10.1 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Venture Financing Deals, 2006-2010
10.2 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Mergers and Acquisitions, 2006-2011
10.3 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Partnerships, 2006-2011
10.4 Key Deals
10.4.1 LETI Forms Partnership with Sorin, TIMA, Cedrat Technologies, Tronics and EASII IC
10.4.2 St. Jude Medical to Invest in Nanostim
10.4.3 Boston Scientific Enters into an Agreement with Fukuda Denshi
10.4.4 MediVed to Secure $5m in Second Round of Financing
11 APPENDIX
11.1 Market Definitions
11.1.1 Pacemakers
11.1.2 Cardiac Resynchronisation Therapy-Pacemakers
11.2 Acronyms
11.3 Sources
11.4 Research Methodology
11.4.1 Secondary Research
11.4.2 Primary Research
11.4.3 Models
11.4.4 Forecasts
11.4.5 Expert Panels
11.5 GlobalData Consulting
11.6 Contact Us
11.7 Disclaimer
LIST OF TABLES
Table 1: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Global, Revenue ($m), 2003-2010
Table 2: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Global, Revenue ($m), 2010-2017
Table 3: Single Chamber Pacemakers versus Dual Chamber Pacemakers, Sales Volume Comparison, by Country, 2010
Table 4: Percentage of Overweight and Obese Population (Aged 15 Years and Above), Global, 2010
Table 5: Diabetes Prevalence Rates, 20-79 Years, by Region, 2007-2010
Table 6: Percentage of Hypertensive Population (25 Years and Above), Global, 2010
Table 7: Percentage of Smoking Population, Global, 2010
Table 8: Percentage of Population aged 65 Years and Older, by Country, 2005-2015
Table 9: Emerging Market Contribution, Global, 2009-2010
Table 10: Demand versus Supply, Developing Economies, 2009
Table 11: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market Revenue ($m) and Growth (%) Comparison, by Country, 2006-2010
Table 12: Dual Chamber Pacemakers, Average Selling Price ($) Comparison, Developed Economies, 2008-2010
Table 13: Single Chamber Pacemakers, Average Selling Price ($) Comparison, Developed Economies, 2008-2010
Table 14: Cardiac Resynchronization Therapy-Pacemakers, Average Selling Price ($) Comparison, Developed Economies, 2008-2010
Table 15: Deference of Healthcare Services, The US, 2006-2009
Table 16: Cardiac Rhythm Management Market, List of Device Recalls, 2004-2010
Table 17: Average Selling Price Comparison ($), Dual Chamber Pacemakers, by Country, 2010
Table 18: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Global, Analysis by Country, Revenue ($m) and Forecast CAGR (2010-2017)
Table 19: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The US, Revenue ($m), 2003-2010
Table 20: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The US, Revenue ($m), 2010-2017
Table 21: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Canada, Revenue ($m), 2003-2010
Table 22: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Canada, Revenue ($m), 2010-2017
Table 23: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The UK, Revenue ($m), 2003-2010
Table 24: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The UK, Revenue ($m), 2010-2017
Table 25: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Germany, Revenue ($m), 2003-2010
Table 26: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Germany, Revenue ($m), 2010-2017
Table 27: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, France, Revenue ($m), 2003-2010
Table 28: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, France, Revenue ($m), 2010-2017
Table 29: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Italy, Revenue ($m), 2003-2010
Table 30: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Italy, Revenue ($m), 2010-2017
Table 31: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Spain, Revenue ($m), 2003-2010
Table 32: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Spain, Revenue ($m), 2010-2017
Table 33: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Japan, Revenue ($m), 2003-2010
Table 34: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Japan, Revenue ($m), 2010-2017
Table 35: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, China, Revenue ($m), 2003-2010
Table 36: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, China, Revenue ($m), 2010-2017
Table 37: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, India, Revenue ($m), 2003-2010
Table 38: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, India, Revenue ($m), 2010-2017
Table 39: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Australia, Revenue ($m), 2003-2010
Table 40: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Australia, Revenue ($m), 2010-2017
Table 41: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Brazil, Revenue ($m), 2003-2010
Table 42: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Brazil, Revenue ($m), 2010-2017
Table 43: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Company Share (%), 2010
Table 44: Adapta, Features and Benefits
Table 45: EnRythm, Features and Benefits
Table 46: Revo MRI SureScan, Features and Benefits
Table 47: Advisa MRI SureScan Pacemaker, Features and Benefits
Table 48: Accent Wireless Single / Dual Chamber Pacemaker, Features and Benefits
Table 49: Entity Dual Chamber Pacemaker, Features and Benefits
Table 50: Affinity, Features and Benefits
Table 51: Identity ADx, Features and Benefits
Table 52: Verity ADx, Features and Benefits
Table 53: Regency, Features and Benefits
Table 54: Microny, Features and Benefits
Table 55: Integrity ADx, Features and Benefits
Table 56: Altrua, Features and Benefits
Table 57: ProMRI, Features and Benefits
Table 58: Evia, Features and Benefits
Table 59: Effecta, Features and Benefits
Table 60: Consulta, Features and Benefits
Table 61: Syncra, Features and Benefits
Table 62: Frontier-II, Features and Benefits
Table 63: Stratos LV-T, Features and Benefits
Table 64: List of Pacemaker in Clinical Development Stage
Table 65: Advisa DR MRI SureScan Pacing System, Status
Table 66: Advisa DR MRI SureScan Pacing System, Clinical Trial
Table 67: Aortic Pacemaker, Status
Table 68: Reply MRI Pacemaker, Product Status
Table 69: Reply MRI Pacemaker, Clinical Trial
Table 70: Ensura MRI SureScan, Status
Table 71: Unconditional MRI Compatible Implantable Pacemaker, Status
Table 72: Accent MRI Pacemaker, Status
Table 73: INGENIO 2 PG - MICS , Status
Table 74: List of Pacemaker in Early Development Stage
Table 75: MicroPort Pacemaker, Status
Table 76: List of Pacemaker in Approval Phase
Table 77: INGENIO Pacemaker System NG, Status
Table 78: List of Pacemaker in Pre-Clinical Development Stage
Table 79: Aortic Pacemaker, Status
Table 80: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market
Table 81: Pacemaker Market, Venture Financing Deals, 2006-2010
Table 82: Pacemaker, Mergers and Acquisitions, 2006-2011
Table 83: Pacemaker Market, Partnerships, 2006-2011
LIST OF FIGURES
Figure 1: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Global, Revenue ($m), 2003-2010
Figure 2: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Global, Revenue ($m), 2010-2017
Figure 3: Single Chamber Pacemakers versus Dual Chamber Pacemakers, Sales Volume Comparison, by Country, 2010
Figure 4: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers, Market Dynamics
Figure 5: Diabetes Prevalence Rates, 20-79 Years, by Region, 2007-2010
Figure 6: Percentage of Hypertensive Population (25 Years and Above), Global, 2010
Figure 7: Percentage of Population Aged 65 Years and Above, by Country, 2005-2015
Figure 8: Emerging Market Contribution, Global, 2009-2010
Figure 9: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market Revenue ($m) and Growth (%) Comparison, by Country, 2006-2010
Figure 10: Evolution in Pacemaker Technology and its Impact on the Market
Figure 11: Dual Chamber Pacemakers, Average Selling Price ($) Comparison, Developed Economies, 2008-2010
Figure 12: Single Chamber Pacemakers, Average Selling Price ($) Comparison, Developed Economies, 2008-2010
Figure 13: Cardiac Resynchronization Therapy-Pacemakers, Average Selling Price ($) Comparison, Developed Economies, 2008-2010
Figure 14: Average Selling Price Comparison ($), Dual Chamber Pacemakers, by Country, 2010
Figure 15: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Global, Analysis by Country, Revenue ($m) and Forecast CAGR(2010-2017)
Figure 16: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The US, Revenue ($m), 2003-2010
Figure 17: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The US, Revenue ($m), 2010-2017
Figure 18: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Canada, Revenue ($m), 2003-2010
Figure 19: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Canada, Revenue ($m), 2010-2017
Figure 20: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The UK, Revenue ($m), 2003-2010
Figure 21: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The UK, Revenue ($m), 2010-2017
Figure 22: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Germany, Revenue ($m), 2003-2010
Figure 23: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Germany, Revenue ($m), 2010-2017
Figure 24: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, France, Revenue ($m), 2003-2010
Figure 25: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, France, Revenue ($m), 2010-2017
Figure 26: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Italy, Revenue ($m), 2003-2010
Figure 27: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Italy, Revenue ($m), 2010-2017
Figure 28: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Spain, Revenue ($m), 2003-2010
Figure 29: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Spain, Revenue ($m), 2010-2017
Figure 30: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Japan, Revenue ($m), 2003-2010
Figure 31: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Japan, Revenue ($m), 2010-2017
Figure 32: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, China, Revenue ($m), 2003-2010
Figure 33: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, China, Revenue ($m), 2010-2017
Figure 34: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, India, Revenue ($m), 2003-2010
Figure 35: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, India, Revenue ($m), 2010-2017
Figure 36: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Australia, Revenue ($m), 2003-2010
Figure 37: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Australia, Revenue ($m), 2010-2017
Figure 38: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Brazil, Revenue ($m), 2003-2010
Figure 39: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Brazil, Revenue ($m), 2010-2017
Figure 40: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Company Share (%), 2010
Figure 41: Pacemaker and Cardiac Resynchronization Therapy-Pacemakers, Key Market Participants Presence in Market Segments, 2010
Figure 42: Medtronic Inc., SWOT Analysis
Figure 43: St. Jude Medical, Inc., SWOT Analysis
Figure 44: BIOTRONIK , SWOT Analysis
Figure 45: Boston Scientific, SWOT Analysis
Figure 46: Sorin S.p.A, SWOT Analysis
Figure 47: Pacemakers Market, Global Pipeline Products
Figure 48: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Deals, 2006-2011
COMPANIES MENTIONED
Medtronic Inc.
St. Jude Medical
BIOTRONIK Inc. GMBH
Boston Scientific
Sorin S.p.A
1.1 List of Tables
1.2 List of Figures
2 INTRODUCTION AND OVERVIEW
2.1 Introduction
2.2 GlobalData Report Guidance
3 DISEASE OVERVIEW: CARDIAC ARRYTHMIA AND CONGESTIVE HEART FAILURE (CHF)
3.1 Cardiac Arrhythmia
3.1.1 Bradycardia
3.1.2 Fibrillation
3.2 Congestive Heart Failure (CHF)
3.2.1 Epidemiology
3.3 Diagnosis of Cardiac Arrythmia and Congestive Heart Failure
3.3.1 Electrocardiography (ECG)
3.3.2 Echocardiogram
3.3.3 Holter Monitor (or Continuous Ambulatory Electrocardiographic Monitor)
3.3.4 Trans-Telephonic Monitor (Event Recorder)
3.3.5 Treadmill Testing
3.3.6 Tilt Table Studies
3.3.7 Electro-Physiologic Testing
3.3.8 Trans-Thoracic Echocardiography (TTE) and Echocardiography
3.3.9 Intra-Cardiac Electro-Physiologic Procedure
3.3.10 Cardiac Catheterization
3.3.11 B-Type Natriuretic Peptide (BNP) Level Test
3.4 Treatment Options for Cardiac Arrythmia and Congestive Heart Failure
3.4.1 Lifestyle Changes
3.4.2 Medications
3.4.3 Invasive Therapies
4 DEVICE OVERVIEW
4.1 Pacemakers
4.1.1 Pacemaker Design
4.1.2 Risk Factors Associated with Pacemakers
4.2 Cardiac Resynchronization Therapy-Pacemakers (CRT-P)
4.2.1 Cardiac Resynchronization Therapy-Pacemakers (CRT-P) Design
4.2.2 Cardiac Resynchronization Therapy-Pacemakers (CRT-P) Risk Factors
4.3 Devices Interfering with the Working of Pacemaker and Cardiac Resynchronization Therapy-Pacemakers (CRT-P)
5 GLOBAL PACEMAKERS AND CARDIAC RESYNCHRONIZATION THERAPY-PACEMAKERS: MARKET CHARACTERIZATION
5.1 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Global, Revenue ($m), Historic, 2003-2010
5.2 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Global, Revenue ($m), Forecast, 2010-2017
5.3 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Key Trend
5.3.1 Single Chamber Pacemakers Registered Higher Sales than Dual Chamber Pacemakers in Developing Economies
5.4 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers, Market Dynamics
5.4.1 Market Drivers
5.4.2 Market Restraints
6 PACEMAKERS AND CARDIAC RESYNCHRONIZATION THERAPY-PACEMAKERS MARKET, ANALYSIS BY COUNTRY, REVENUE ($M), 2010-2017
6.1 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The US, Revenue ($m), Historic, 2003-2010
6.2 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The US, Revenue ($m), Forecast, 2010-2017
6.3 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Canada, Revenue ($m), Historic, 2003-2010
6.4 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Canada, Revenue ($m), Forecast, 2010-2017
6.5 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The UK, Revenue ($m), Historic, 2003-2010
6.6 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The UK, Revenue ($m), Forecast, 2010-2017
6.7 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Germany, Revenue ($m), Historic, 2003-2010
6.8 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Germany, Revenue ($m), Forecast, 2010-2017
6.9 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, France, Revenue ($m), Historic, 2003-2010
6.10 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, France, Revenue ($m), Forecast, 2010-2017
6.11 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Italy, Revenue ($m), Historic, 2003-2010
6.12 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Italy, Revenue ($m), Forecast, 2010-2017
6.13 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Spain, Revenue ($m), Historic, 2003-2010
6.14 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Spain, Revenue ($m), Forecast, 2010-2017
6.15 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Japan, Revenue ($m), Historic, 2003-2010
6.16 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Japan, Revenue ($m), Forecast, 2010-2017
6.17 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, China, Revenue ($m), Historic, 2003-2010
6.18 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, China, Revenue ($m), Forecast, 2010-2017
6.19 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, India, Revenue ($m), Historic, 2003-2010
6.20 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, India, Revenue ($m), Forecast, 2010-2017
6.21 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Australia, Revenue ($m), Historic, 2003-2010
6.22 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Australia, Revenue ($m), Forecast, 2010-2017
6.23 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Brazil, Revenue ($m), Historic, 2003-2010
6.24 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Brazil, Revenue ($m), Forecast, 2010-2017
7 PACEMAKERS AND CARDIAC RESYNCHRONIZATION THERAPY-PACEMAKERS MARKET: STRATEGIC COMPETITIVE ASSESSMENT
7.1 Pacemaker and Cardiac Resynchronization Therapy-Pacemakers, Key Market Participants
7.1.1 Medtronic Inc.
7.1.2 St. Jude Medical
7.1.3 BIOTRONIK Inc. GMBH
7.1.4 Boston Scientific
7.1.5 Sorin S.p.A
8 PACEMAKERS AND CARDIAC RESYNCHRONIZATION THERAPY-PACEMAKERS, KEY MARKETED PRODUCTS
8.1 Adapta, Dual Chamber Pacemaker, Medtronic Inc.
8.1.1 Features and Benefits
8.2 EnRythm, Dual Chamber Pacemaker, Medtronic Inc.
8.2.1 Features and Benefits
8.3 Revo MRI SureScan, MRI Safe Dual Chamber Pacemaker, Medtronic Inc.
8.3.1 Features and Benefits
8.4 Advisa MRI SureScan Pacemaker, Dual Chamber MRI Safe Pacemaker, Medtronic Inc.
8.4.1 Features and Benefits
8.5 Accent Wireless Single/Dual Chamber Pacemaker, St. Jude Medical
8.5.1 Features and Benefits
8.6 Entity Dual Chamber Pacemaker, St. Jude Medical
8.6.1 Features and Benefits
8.7 Affinity Dual Chamber Pacemaker, St. Jude Medical
8.7.1 Features and Benefits
8.8 Identity ADx Dual Chamber Pacemaker, St. Jude Medical
8.8.1 Features and Benefits
8.9 Verity ADx Dual Chamber Pacemaker, St. Jude Medical
8.9.1 Features and Benefits
8.10 Regency Single Chamber Pacemaker, St. Jude Medical
8.10.1 Features and Benefits
8.11 Microny Single Chamber Pacemaker, St. Jude Medical
8.11.1 Features and Benefits
8.12 Integrity ADx Dual Chamber Pacemaker, St. Jude Medical
8.12.1 Features and Benefits
8.13 Altrua Group of Single/Dual Chamber Pacemaker, Boston Scientific
8.13.1 Features and Benefits
8.14 ProMRI MRI Safe Single/Dual Chamber Pacemaker, BIOTRONIK
8.14.1 Features and Benefits
8.15 Evia Single/Dual Chamber Pacemaker, BIOTRONIK
8.15.1 Features and Benefits
8.16 Effecta Dual Chamber Pacemaker, BIOTRONIK
8.16.1 Features and Benefits
8.17 Consulta, Medtronic Inc.
8.17.1 Features and Benefits
8.18 Syncra, Medtronic Inc.
8.18.1 Features and Benefits
8.19 Frontier-II, St. Jude Medical
8.19.1 Features and Benefits
8.20 Stratos LV-T, BIOTRONIK
8.20.1 Features and Benefits
9 PACEMAKERS MARKET: STRATEGIC PIPELINE ASSESSMENT
9.1 Pacemakers in Clinical Development Stage
9.1.1 Advisa DR MRI SureScan Pacing System, Medtronic, Inc.
9.1.2 ECN Pacemaker, Mathematical Bio-Solutions, Inc.
9.1.3 Reply MRI Pacemaker, Sorin Group
9.1.4 Ensura MRI SureScan Pacing System, Medtronic, Inc.
9.1.5 Unconditional MRI Compatible Implantable Pacemaker, Kenergy Inc.
9.1.6 Accent MRI Pacemaker, St. Jude Medical
9.1.7 INGENIO 2 PG - MICS, Boston Scientific Corporation
9.2 Pacemaker in Early Development Stage
9.2.1 MicroPort Pacemaker, MicroPort Scientific Corporation
9.3 Pacemakers in Approval Phase
9.3.1 INGENIO Pacemaker System NG, Boston Scientific Corporation
9.4 Pacemakers in Pre-Clinical Development Stage
9.4.1 Aortic Pacemaker
10 PACEMAKERS AND CARDIAC RESYNCHRONIZATION THERAPY-PACEMAKERS MARKET, STRATEGIC DEALS ANALYSIS
10.1 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Venture Financing Deals, 2006-2010
10.2 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Mergers and Acquisitions, 2006-2011
10.3 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Partnerships, 2006-2011
10.4 Key Deals
10.4.1 LETI Forms Partnership with Sorin, TIMA, Cedrat Technologies, Tronics and EASII IC
10.4.2 St. Jude Medical to Invest in Nanostim
10.4.3 Boston Scientific Enters into an Agreement with Fukuda Denshi
10.4.4 MediVed to Secure $5m in Second Round of Financing
11 APPENDIX
11.1 Market Definitions
11.1.1 Pacemakers
11.1.2 Cardiac Resynchronisation Therapy-Pacemakers
11.2 Acronyms
11.3 Sources
11.4 Research Methodology
11.4.1 Secondary Research
11.4.2 Primary Research
11.4.3 Models
11.4.4 Forecasts
11.4.5 Expert Panels
11.5 GlobalData Consulting
11.6 Contact Us
11.7 Disclaimer
LIST OF TABLES
Table 1: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Global, Revenue ($m), 2003-2010
Table 2: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Global, Revenue ($m), 2010-2017
Table 3: Single Chamber Pacemakers versus Dual Chamber Pacemakers, Sales Volume Comparison, by Country, 2010
Table 4: Percentage of Overweight and Obese Population (Aged 15 Years and Above), Global, 2010
Table 5: Diabetes Prevalence Rates, 20-79 Years, by Region, 2007-2010
Table 6: Percentage of Hypertensive Population (25 Years and Above), Global, 2010
Table 7: Percentage of Smoking Population, Global, 2010
Table 8: Percentage of Population aged 65 Years and Older, by Country, 2005-2015
Table 9: Emerging Market Contribution, Global, 2009-2010
Table 10: Demand versus Supply, Developing Economies, 2009
Table 11: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market Revenue ($m) and Growth (%) Comparison, by Country, 2006-2010
Table 12: Dual Chamber Pacemakers, Average Selling Price ($) Comparison, Developed Economies, 2008-2010
Table 13: Single Chamber Pacemakers, Average Selling Price ($) Comparison, Developed Economies, 2008-2010
Table 14: Cardiac Resynchronization Therapy-Pacemakers, Average Selling Price ($) Comparison, Developed Economies, 2008-2010
Table 15: Deference of Healthcare Services, The US, 2006-2009
Table 16: Cardiac Rhythm Management Market, List of Device Recalls, 2004-2010
Table 17: Average Selling Price Comparison ($), Dual Chamber Pacemakers, by Country, 2010
Table 18: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Global, Analysis by Country, Revenue ($m) and Forecast CAGR (2010-2017)
Table 19: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The US, Revenue ($m), 2003-2010
Table 20: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The US, Revenue ($m), 2010-2017
Table 21: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Canada, Revenue ($m), 2003-2010
Table 22: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Canada, Revenue ($m), 2010-2017
Table 23: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The UK, Revenue ($m), 2003-2010
Table 24: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The UK, Revenue ($m), 2010-2017
Table 25: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Germany, Revenue ($m), 2003-2010
Table 26: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Germany, Revenue ($m), 2010-2017
Table 27: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, France, Revenue ($m), 2003-2010
Table 28: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, France, Revenue ($m), 2010-2017
Table 29: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Italy, Revenue ($m), 2003-2010
Table 30: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Italy, Revenue ($m), 2010-2017
Table 31: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Spain, Revenue ($m), 2003-2010
Table 32: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Spain, Revenue ($m), 2010-2017
Table 33: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Japan, Revenue ($m), 2003-2010
Table 34: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Japan, Revenue ($m), 2010-2017
Table 35: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, China, Revenue ($m), 2003-2010
Table 36: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, China, Revenue ($m), 2010-2017
Table 37: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, India, Revenue ($m), 2003-2010
Table 38: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, India, Revenue ($m), 2010-2017
Table 39: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Australia, Revenue ($m), 2003-2010
Table 40: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Australia, Revenue ($m), 2010-2017
Table 41: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Brazil, Revenue ($m), 2003-2010
Table 42: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Brazil, Revenue ($m), 2010-2017
Table 43: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Company Share (%), 2010
Table 44: Adapta, Features and Benefits
Table 45: EnRythm, Features and Benefits
Table 46: Revo MRI SureScan, Features and Benefits
Table 47: Advisa MRI SureScan Pacemaker, Features and Benefits
Table 48: Accent Wireless Single / Dual Chamber Pacemaker, Features and Benefits
Table 49: Entity Dual Chamber Pacemaker, Features and Benefits
Table 50: Affinity, Features and Benefits
Table 51: Identity ADx, Features and Benefits
Table 52: Verity ADx, Features and Benefits
Table 53: Regency, Features and Benefits
Table 54: Microny, Features and Benefits
Table 55: Integrity ADx, Features and Benefits
Table 56: Altrua, Features and Benefits
Table 57: ProMRI, Features and Benefits
Table 58: Evia, Features and Benefits
Table 59: Effecta, Features and Benefits
Table 60: Consulta, Features and Benefits
Table 61: Syncra, Features and Benefits
Table 62: Frontier-II, Features and Benefits
Table 63: Stratos LV-T, Features and Benefits
Table 64: List of Pacemaker in Clinical Development Stage
Table 65: Advisa DR MRI SureScan Pacing System, Status
Table 66: Advisa DR MRI SureScan Pacing System, Clinical Trial
Table 67: Aortic Pacemaker, Status
Table 68: Reply MRI Pacemaker, Product Status
Table 69: Reply MRI Pacemaker, Clinical Trial
Table 70: Ensura MRI SureScan, Status
Table 71: Unconditional MRI Compatible Implantable Pacemaker, Status
Table 72: Accent MRI Pacemaker, Status
Table 73: INGENIO 2 PG - MICS , Status
Table 74: List of Pacemaker in Early Development Stage
Table 75: MicroPort Pacemaker, Status
Table 76: List of Pacemaker in Approval Phase
Table 77: INGENIO Pacemaker System NG, Status
Table 78: List of Pacemaker in Pre-Clinical Development Stage
Table 79: Aortic Pacemaker, Status
Table 80: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market
Table 81: Pacemaker Market, Venture Financing Deals, 2006-2010
Table 82: Pacemaker, Mergers and Acquisitions, 2006-2011
Table 83: Pacemaker Market, Partnerships, 2006-2011
LIST OF FIGURES
Figure 1: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Global, Revenue ($m), 2003-2010
Figure 2: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Global, Revenue ($m), 2010-2017
Figure 3: Single Chamber Pacemakers versus Dual Chamber Pacemakers, Sales Volume Comparison, by Country, 2010
Figure 4: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers, Market Dynamics
Figure 5: Diabetes Prevalence Rates, 20-79 Years, by Region, 2007-2010
Figure 6: Percentage of Hypertensive Population (25 Years and Above), Global, 2010
Figure 7: Percentage of Population Aged 65 Years and Above, by Country, 2005-2015
Figure 8: Emerging Market Contribution, Global, 2009-2010
Figure 9: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market Revenue ($m) and Growth (%) Comparison, by Country, 2006-2010
Figure 10: Evolution in Pacemaker Technology and its Impact on the Market
Figure 11: Dual Chamber Pacemakers, Average Selling Price ($) Comparison, Developed Economies, 2008-2010
Figure 12: Single Chamber Pacemakers, Average Selling Price ($) Comparison, Developed Economies, 2008-2010
Figure 13: Cardiac Resynchronization Therapy-Pacemakers, Average Selling Price ($) Comparison, Developed Economies, 2008-2010
Figure 14: Average Selling Price Comparison ($), Dual Chamber Pacemakers, by Country, 2010
Figure 15: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Global, Analysis by Country, Revenue ($m) and Forecast CAGR(2010-2017)
Figure 16: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The US, Revenue ($m), 2003-2010
Figure 17: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The US, Revenue ($m), 2010-2017
Figure 18: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Canada, Revenue ($m), 2003-2010
Figure 19: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Canada, Revenue ($m), 2010-2017
Figure 20: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The UK, Revenue ($m), 2003-2010
Figure 21: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The UK, Revenue ($m), 2010-2017
Figure 22: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Germany, Revenue ($m), 2003-2010
Figure 23: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Germany, Revenue ($m), 2010-2017
Figure 24: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, France, Revenue ($m), 2003-2010
Figure 25: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, France, Revenue ($m), 2010-2017
Figure 26: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Italy, Revenue ($m), 2003-2010
Figure 27: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Italy, Revenue ($m), 2010-2017
Figure 28: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Spain, Revenue ($m), 2003-2010
Figure 29: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Spain, Revenue ($m), 2010-2017
Figure 30: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Japan, Revenue ($m), 2003-2010
Figure 31: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Japan, Revenue ($m), 2010-2017
Figure 32: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, China, Revenue ($m), 2003-2010
Figure 33: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, China, Revenue ($m), 2010-2017
Figure 34: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, India, Revenue ($m), 2003-2010
Figure 35: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, India, Revenue ($m), 2010-2017
Figure 36: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Australia, Revenue ($m), 2003-2010
Figure 37: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Australia, Revenue ($m), 2010-2017
Figure 38: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Brazil, Revenue ($m), 2003-2010
Figure 39: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Brazil, Revenue ($m), 2010-2017
Figure 40: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Company Share (%), 2010
Figure 41: Pacemaker and Cardiac Resynchronization Therapy-Pacemakers, Key Market Participants Presence in Market Segments, 2010
Figure 42: Medtronic Inc., SWOT Analysis
Figure 43: St. Jude Medical, Inc., SWOT Analysis
Figure 44: BIOTRONIK , SWOT Analysis
Figure 45: Boston Scientific, SWOT Analysis
Figure 46: Sorin S.p.A, SWOT Analysis
Figure 47: Pacemakers Market, Global Pipeline Products
Figure 48: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Deals, 2006-2011
COMPANIES MENTIONED
Medtronic Inc.
St. Jude Medical
BIOTRONIK Inc. GMBH
Boston Scientific
Sorin S.p.A
